Next Article in Journal
Wellbeing in Workers during COVID-19 Pandemic: The Mediating Role of Self-Compassion in the Relationship between Personal Resources and Exhaustion
Next Article in Special Issue
Clinical Validation of a Deep-Learning Segmentation Software in Head and Neck: An Early Analysis in a Developing Radiation Oncology Center
Previous Article in Journal
Macroeconomic and Social Indicators to Launch the PM-Based VBHC Model in the Healthcare System in Poland
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tumours of Nasal Septum: A Retrospective Study of 32 Patients

by
Federico Sireci
1,*,
Francesco Dispenza
1,
Francesco Lorusso
1,
Angelo Immordino
1,
Palmira Immordino
2,
Salvatore Gallina
1,
Giorgio Peretti
3,4 and
Frank Rikki Canevari
3,4
1
Otorhinolaryngology Section, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND) University of Palermo, 90100 Palermo, Italy
2
Hygiene and Preventive Medicine Section, Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialities (PROMISE), University of Palermo, 90100 Palermo, Italy
3
IRCCS Ospedale Policlinico San Martino, 16100 Genoa, Italy
4
Unit of Otorhinolaryngology—Head and Neck Surgery, University of Genoa, 16100 Genoa, Italy
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(3), 1713; https://doi.org/10.3390/ijerph19031713
Submission received: 19 November 2021 / Revised: 26 January 2022 / Accepted: 30 January 2022 / Published: 2 February 2022
(This article belongs to the Special Issue Head and Neck Cancers: What's New?)

Abstract

:
Objective: Tumours of the nasal septum are a rare and heterogeneous group of lesions in the sinonasal tract. The management of the different lesions of this site is debated. The aim of this study is to share our experience on a rare clinical condition and stimulate other centres to publish theirs. Methods: We retrospectively analysed the databases of sinonasal tumours treated at the Sections of Otolaryngology (ENT) of two University Hospitals (Palermo and Genova) between 2012 and 2020. Results: From the two databases, a cohort of 32 patients with tumours of nasal septum were selected. All patients underwent an endoscopic examination. Large tumours underwent preoperative computed tomography (CT) scan without contrast medium. In 22 (68.7%) cases, the preoperative radiologic evaluation also included magnetic resonance imaging (MRI) with gadolinium to obtain a better differentiation of the lesions and study the vascular pattern. All the large lesions were biopsied under endoscopic guidance using local anaesthesia; the same approach was used to remove the tumours and their attachment with safe resection margins. Conclusions: While malignant lesions require an excision of the mass with resection of all layers of the nasal septum, benign lesions must be typed according to histological considerations in order to plan the most appropriate type of surgical resection.

1. Introduction

Tumours of the nasal septum belong to a rare and heterogeneous group of lesions in the sinonasal tract. According to the published literature, the incidence of benign neoplasms is not known since many of them occur sporadically in the sinonasal area [1]. Lobular capillary haemangioma (pyogenic granuloma) seems to be the most frequent, with a percentage between 7 and 29% [2], followed by inverted papilloma (2.5%) and pleomorphic adenoma [3]. Scarce information is available about malignancies, representing 9% of all sinonasal cancers [4] and being more common in males and persons older than 50 years. The incidence and histological type can vary in different geographical areas, probably due to occupational, social and genetic factors. As a result, the distribution in the literature is variable [5]. The management of the different lesions of this site is debated because the resection of all the layers of nasal septum (mucoperiosteum/mucoperichondrium bilateral with the cartilage/bone) or some of these (mucoperiosteum/mucoperichondrium unilateral with or without the cartilage/bone) is not coded by the guidelines [6,7]. For this reason, the aim of this study is to present our experience about the tumours of nasal septum and try to standardize the management and surgical approach to these lesions.

2. Materials and Method

2.1. Study Design

We performed a retrospective analysis of the databases of sinonasal tumours treated at the Sections of Otolaryngology of two University Hospitals (Palermo and Genova) between 2012 and 2020. Only primary tumours with origin from the nasal septum were included in the study. Clinical, demographic, histologic, radiographic characteristics, as well as operative and post-operative findings, complications, adjuvant therapy and follow-up data were analysed.

2.2. Pre-Operative Workup and Surgical Treatment

All patients underwent endonasal endoscopy to evaluate the extension of the neoplasm. Small lesions (i.e., diameter ≤ 2 mm) were removed by endoscopic resection in local anaesthesia without imaging. In the large tumours (i.e., diameter > 2 mm), a CT scan and/or a contrast-enhanced MRI were/was performed to study the lesions, if imaging was not clear about the involvement of other anatomical structures and/or endoscopy did not show a secure implant base, a biopsy under local anaesthesia was always performed, to be followed by endoscopic resection in general anaesthesia. About the malignancies, the adjuvant therapy was discussed with multidisciplinary team, and it was used for the cases with involved margins, advanced staging (III–IV) or grading (high grade) and involvement of critical regions, such as frontal sinus, sphenoid sinus, anterior skull base (with or without dural infiltration), lamina papyracea or periorbit and nasopharynx.

2.3. Follow-Up

Postoperative follow-up was performed with nasal endoscopy every 15 days until complete healing of the surgical cavity, every 3 months during the first year and every 6 months thereafter. Post-operative MRI with gadolinium was performed 6 months after surgery and every year thereafter for the large tumours. For the malignancy, systemic staging through total body positron emission tomography (PET) or total body CT scan and ultrasound of the neck was performed once a year. In the small lesions, an endoscopic exam was considered to be enough.

3. Results

A cohort of 32 patients with tumours of the nasal septum were detected, including 19 males and 13 females (M:F = 1.5:1). The mean age was about 56.24 years (SD ± 14.69 years) with a range from 14 to 86 years.
In 17 patients (53.1%), the symptom was unilateral nasal obstruction, 10 (31.2%) reported unilateral epistaxis and 4 (12.5%) reported unilateral epistaxis and nasal obstruction [8]. One (3.1%) patient was asymptomatic. In 19 patients (59.4%), the lesion was on the right nostril, in 12 (37.5%) on the left and in 1 (3.1%) case bilateral.
All patients with large tumours underwent a preoperative CT scan without contrast medium to study the bone anatomical limits that can be invaded by the lesion. Often the contrast medium can give information on vascularization, but it is not useful for the typization of the tumour. In 22 (68.7%) cases, the preoperative radiologic evaluation also included an MRI with gadolinium to obtain a better differentiation of the lesion and to study the vascular pattern. In cases of malignancies, the presence of local or distant metastases was assessed with a total-body contrast-enhanced CT scan and ultrasound of the neck.
In cases of small tumours, an endoscopic resection was performed, while in the large lesions, a biopsy preceded the surgery.
All the specimens were sent to the Department of Human Pathology for histopathological diagnosis. A total of 28 (87.5%) cases were benign neoplasm, of which 9 (28.1%) patients had a lobular capillary haemangioma (LCH), also called pyogenic granuloma; 13 (40.6%) had an inverted papilloma (IP); and 1 (3.1%) case of Schwannoma, 1 Warthin’s tumour (WT), 1 respiratory epithelial adenomatoid hamartoma (REAH), 1 Pleomorphic Adenoma (PA), 1 blue nevus (BN) and 1 solitary fibrous tumour (SFT). Four (12.5%) cases were malignant tumours, of which one was Mucosal Melanoma (MM), one was non-Intestinal-type adenocarcinoma (n-ITAC), one was poorly differentiated non-keratinizing squamous cell carcinoma (SCC) and one was low grade chondrosarcoma (Table 1). Based on the clinical, radiological and histopathological findings, all neoplasms were staged according to the system of Krouse for inverted papilloma [9] and the 2016 Union for International Cancer Control TNM classification [10] for the malignancies.
The biopsied cases with histological diagnosis of benign neoplasm underwent endoscopic resection, whereas, in cases of malignancies, the presence of local or distant metastases was assessed with a total-body contrast-enhanced CT scan and an ultrasound of the neck. Treatment planning based on a common management strategy was discussed by the multidisciplinary team. In the cases of benign tumours, a partial resection of the nasal septum was performed. In particular:
-
In the lobular capillary haemangioma, only the mucoperichondrium was removed.
-
In the others lesions, the mucoperichondrium with cartilage and/or bone was removed.
In all malignant tumours, an endoscopic endonasal resection without external approach was possible, and a resection of all layers of nasal septum was performed [8]. In some of these cases, a resection of the nasal septum was not enough, and therefore the resection was completed by other surgical steps: nasopharyngeal endoscopic resection (NER) type II for the n-ITAC; bilateral medial maxillectomy for the chondrosarcoma; and bilateral selective neck dissection (SND I-III) for the MM. No intraoperative or postoperative complications occurred. In all patients, nasal packing was removed within 48 h, and the antibiotic therapy (i.e., intravenous cephalosporin) was administered the day before surgery and continued for at least 5 days. Irrigations with saline solution (twice a day) were recommended for at least 1 month [11]. Two malignant cases (mucosal melanoma and n-ITAC) were subjected to postoperative adjuvant radiotherapy (RT). Follow-up data were available for all patients and ranged from 12 to 60 (mean, 28.2) months. From the follow-up carried out, all patients have been disease free to date.

4. Discussion

The nasal septum is supported by a plate of hyaline cartilage (quadrangular cartilage) and a plate of bone (perpendicular lamina of ethmoid and vomer) covered by respiratory epithelium (pseudostratified ciliated columnar). This structure is mainly made ofciliated columnar and goblet cells attached to a basal lamina. Basal cells are observed just above the basal lamina. Septal glands with their ducts, vessels and nerves are present in lamina propria or rather mucoperiosteum/mucoperichondrium. The glands are not the same in all the septums: the anterior glands of the nasal septum are tubulo-alveolar with a serous secretion; the posterior glands are of the branched acinar type with a mucoid secretion. They lie partly within the vomeronasal capsule and most of the ducts of the posterior glands open into the cavity of the vomeronasal organ along the groove between the olfactory and columnar epithelia [12]. To synthesise our experience and the fragmented literature on the tumours of nasal septum, we started from histological considerations. In our cohort, 87.5% of the cases were benign tumours vs. 12.5% of malignant lesions, in line with existing published literature (Figure 1; Table 2).
The most frequent tumour was lobular capillary haemangioma (LCH) (28.1%; M:F = 2:7). This one, also known as pyogenic granuloma, is a benign vascular tumour with a microscopically distinctive lobular architecture that affects the skin and mucous membranes of the oral cavity and nasal region. The disease may appear in all ages. According to published literature, the incidence of this lesion is variable (7–29%), probably because its presence may be underestimated as it is confused with a bleeding angioma, and therefore small LCHs are simply electrocauterized. Usually, this lesion, if smaller than 1 cm, arises from the anterior portion of the nasal septum. In this case, imaging studies are not indicated, unless a differential diagnosis is needed (e.g., angiofibroma, angiomatous polyp, haemangioma, hemangiopericytoma, paraganglioma, angiosarcoma and highly vascularised metastases such as kidney, thyroid, lung or breast; schwannoma with Antoni A histological pattern). Endoscopic surgery is the treatment of choice for LCH. In particular, small size lesions, as in our cases, can be resected easily under local anaesthesia. Since the lesion is benign and the vessels of the nasal septum are contained in the mucopericondrium/periosteal, Puxeddu et al. suggest a radical resection on the subperichondrial or a subperiosteal plane with a margin of normal mucosa all around [13].
About benign epithelial lesions, the IP was present in 40.6% of cases, followed by 2 cases of salivary-gland-type adenomas (one PA and one WT) and 1 case of REAH. This high incidence compared to the available literature analysed (40% vs. 2.5%) is explained by the fact that our centres represent the local referral hospital for neoplastic pathology of the nasosinusal district, and therefore, we receive the most complex cases (e.g., IP) for surgical treatment. Usually, IP arises primarily from the lateral nasal wall and rarely from the nasal septum. Likely, focal hyperostosis, osteitis or bone remodelling are CT radiographic predictors of tumour origin or attachment. Histologically, IP shows an epithelium inverting into the stroma but with a distinct and intact basement membrane that separates both. However, the tumour may be associated with atypia, dysplasia and carcinoma in situ, as well as frank squamous cell carcinoma identified focally only with the definitive histological examination also in the area of hyperostosis. For this reason, endoscopic resection must foresee the excision of mucoperhicondrium/ostium with cartilage/bone with safety margin [14].
Salivary gland-type adenomas arise from minor salivary glands of the sinonasal tract. In particular, PA must be carefully assessed because a malignant transformation into carcinoma ex-pleomorophic adenoma (CXPA) occurs in approximately 6% of cases. Considering the presence of the glands in the stroma, the literature suggests a complete surgical excision of the tumour with clear resection margins by endonasal endoscopic resection of the mucoperhicondrium/ostium. Luckily, the treated PA of the nasal septum are significantly associated with a low prevalence of recurrence compared to tumour originating from the paranasal sinus [15,16]. Our case of WT of nasal septum is the first in the literature. It seems to originate from the undifferentiated epithelium of the intercalated ducts of the glands. The pathogenesis of these tumours is uncertain. Clinically, they may be similar to a mucocele. Compared to PA, these lesions are mainly benign without a possible evolution into malignant lesions. Considering that they belong to the same histopathological category of PA, the approach suggested is the same [17].
Another benign epithelial tumour is the respiratory epithelial adenomatoid hamartoma (REAH). Hamartoma can grow out in each part of the body and can be defined as epithelial, mesenchymal and mixed. In the sinonasal region, the majority of them are purely of epithelial type and are called REAHs. Its origin is from the surface epithelium with glandular elements arising from this epithelium and not from seromucous glands (unlike salivary-gland-type adenomas). They may appear as either isolated lesions or in association with inflammatory processes such as sinonasal polyposis. The majority of REAHs arise from the posterior nasal septum like our case, but some cases may arise from the olfactory cleft, middle meatus, inferior turbinate, maxillary sinus, nasopharynx and sphenoid sinus. Our case of REAH was in the right nostril between the septum and the olfactory cleft [15]. Differently from IP, the benign epithelial origin of this lesion suggests a muchoperichondral excision. In fact, both surgical treatments (less and more aggressive) resulted indeed to be effective to remove the REAH, and therefore a less aggressive and more conservative approach is sufficient for dealing with this kind of lesions [18,19].
The only “Benign soft tissue tumours” present in our records was the Schwannoma [20].
It is a neurogenic, slowly growing tumour which originates from Schwann cells of the sheath of the peripheral nerves. It can arise from any peripheral cranial nerve, with the exception of the olfactory and optic nerves. Only 4% of the head and neck Schwannomas originate from the nasal cavity and paranasal sinuses, often arising from the ophthalmic-maxillary branches of the trigeminal nerve and from the sympathetic parasympathetic nerves [19]. The risk of malignancy for Schwannomas is very low and increases predominantly to 10–15% in Von Recklinghausen’s disease [21].
According to the literature, as well as in our cases, the most frequent site of Schwannoma is the posterior nasal septum followed by the midportion and anterior nasal septum. Although it is unusual to identify a particular nerve of origin, the possible source for nasal septal schwannoma includes the sympathetic nerve to the septal blood vessels, the parasympathetic nerve to the septal mucous glands and the sensory nerve to the septum. Actually, there are no studies explaining the reason why nasal septal schwannomas arise from the posterior portion of the nasal septum, but considering that nerves are present in the stroma, an excision of the mucoperhicondrium/ostium extended to cartilage/bone is mandatory to be effective in this case.
Concerning the “Borderline and low malignant potential tumours of soft tissue”, the only case was an extrapleural solitary fibrous tumour (SFT). This lesion typically involves the pleura but can rarely be present in another district. It is defined as a fibroblastic/myofibroblastic neoplasm, slowly growing, rarely metastasizing and with intermediate biological behaviour. Although most SFTs have a good prognosis, about 10–40% of cases relapse or metastasize. For instance, its clinically aggressive behaviour is related to the pathological criteria of malignancy established by the World Health Organization (WHO) as follows: presence of hypercellularity, increased mitoses (>4 mitoses per 10 high power elds), cytological atypia, tumour necrosis and/or infiltrative margins. In our case, the patient had benign histological criteria, and therefore, surgery without chemoradiotherapy was the treatment of choice. In particular, an endoscopic resection of the mass with excision of its attachment to the mucoperichondrium with cartilage was performed because, also in this lesion, malignancy is established only in the definitive histological examination, and the cartilage/bone often present hyperostosis [22] (Figure 2a).
Out of the 32 cases, 2 of them were “neuroectodermal tumours”: a blue nevus (BN, benign) and a mucosal melanoma (MM, malignant). The BN is a very rare lesion (only 5 cases are described in the literature) and goes in the differential diagnosis of pigmented lesions. It is characteristically small and asymptomatic, and the diagnosis is only histological. Treatment is complete excision (bilateral mucopericondrium and cartilage) for diagnostic and therapeutic purposes. The risk of recurrence is very low. Differently, in case of MM, patients often come late to medical observation because it grows asymptomatically until the last disease course. This lesion is rare (accounting for between 0.3% and 2% of all malignant melanomas and about 4% of head and neck melanomas) and more frequent in black patients. The primary approach is surgical resection [23]. Postoperative radiotherapy may help local control but does not affect survival. Prophylactic neck dissection in an N0 neck is not recommended as the incidence of node metastases is relatively low. Our patient presented cN2c in the imaging, and therefore, a bilateral selective neck dissection (SND I-III) was performed. One of the challenges of melanoma is the local recurrence. A long-term follow-up is indeed mandatory. When it occurs in sinonasal district, it is associated with poor survival rates, except for locations on the nasal septum where prognosis is better. In line with international literature [24], our case of MM was treated with an endoscopic resection of the mass with all layers of the nasal septum. Although histopathological examination evidenced free margins, due to the presence of pN2c, adjuvant radiotherapy was performed to improve local control of the primary lesion. This case is to date free of disease.
Concerning the “Malignant tumours of bone and cartilage”, the only case present was a low-grade chondrosarcoma. This lesion is a slowly growing malignancy of cartilage that arises from remnants of cartilage after ossification [25]. Three different gradings are possible, and this parameter with resection margins is the most important predictors of local recurrence and metastasis.
If possible, en-bloc excision is the preferred surgical treatment because these lesions are partially radio-resistant. Chondrosarcomas, especially low-grade tumours, are associated with an excellent prognosis if the lesions are completely resected. Our case showed an involvement of bilateral layers of nasal septum and bilateral invasion of the medial wall of the maxillary sinus (Figure 2b). Therefore, according to the literature, when these lesions involve the septum and the posterior septum and sphenoid rostrum without skull base or orbital involvement, they can be treated with a total endoscopic resection, including all layers of the nasal septum. Since the tumour histologically origins from cartilage, contralateral muchopericondrium must be removed to have margins free. Adjuvant radiotherapy was performed because the histopathology evidenced free margins and low grading [26,27,28,29]. Concerning the “malignant epithelial tumours”, we had two cases: a patient with a non-intestinal-type adenocarcinoma (n-ITAC) and Squamous Cell Carcinoma. While n-ITACs with ITAC are a glandular malignancy with a different prognosis, ITAC is generally locally aggressive with a local recurrence rate of around 50%, local lymph node spread in about 10% of the cases, a distant metastasis rate of 20% [29,30,31,32] and the 5-year survival is 40 to 60%. N-ITACs are divided into low- and high-grade subtypes. Low-grade N-ITAC has a more indolent course with an excellent prognosis, with 5-year survival up to 85%, while high-grade tumours may present extension of the neighbouring districts and have a very poor prognosis, with a 3-year survival of around 20% [33]. In our case, the tumour was a low-grade n-ITAC arising from vomer and involving rhinopharynx with the erosion of basisphenoid bone. Therefore, an endoscopic resection of the mass with all layers of the nasal septum with margins free and a nasopharyngeal endoscopic resection type II (NER 2) was performed. Although the tumour was margins free and low grade, it involved a critical region (sphenoid sinus and nasopharynx), and therefore, adjuvant radiotherapy was performed.
Squamous cell carcinoma (SCC) is the most common malignancy of the sinonasal tract. The peak incidence is between 60 and 70 years of age and it is more frequent in men than women (M:F = 2:1) [34]. An association between SCC and nickel exposure has been shown by Pedersen et al. Inverted papilloma is also associated with SCC in approximately 10% of the cases and can be synchronous (7.1%) or metachronous (3.6%) [35,36]. Nodal metastasis in paranasal SCCs are associated with a poor prognosis. SCC of the paranasal sinuses has a high propensity for neural invasion. Our case was a primary SCC of the vomer. An endoscopic resection with all layers of the nasal septum was performed. Adjuvant radiotherapy was not performed because margins were free, and the stage was II without the involvement of critical regions or of the lymph nodes.

5. Conclusions

Nasal septal tumours are a heterogeneous group of rare lesions even compared to other neoplasms of the nasosinusal tract. CT and RM are the gold standard for diagnosis overall for large lesions in which a biopsy is mandatory. While malignant lesions require an excision of the mass with resection of all layers of the nasal septum, benign lesion must be typed according to histological considerations in order to plan the most appropriate type of surgical resection. In line with the available literature in the field, we performed a mucoperichondrium with cartilage/bone excision in patients with IP, Schwannoma and SFT, while an excision of mucoperichondrium was performed for LCH, WT, PA and REAH (Figure 3). The endoscopic approach is indicated for a minor comorbidity and post-operative hospitalization. In our experience, when margins were free, there was no recurrence of the disease in the follow-up. A multicentre study could allow us to identify more precise guidelines for the management of these neoplasms.

Author Contributions

Conceptualization, F.S. and F.R.C.; Methodology, A.I. and F.L.; Investigation, F.D.; Writing—Original Draft Preparation, P.I.; Supervision, S.G. and G.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study did not require ethical approval.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are not publicly available due to privacy restrictions.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lund, V.J.; Stammberger, H.; Nicolai, P.; Castelnuovo, P.; Beal, T.; Beham, A.; Bernal-Sprekelsen, M.; Braun, H.; Cappabianca, P.; Carrau, R. European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol. Suppl. 2010, 22, 1–143. [Google Scholar] [PubMed]
  2. Jafek, B.W.; Wood, R.P.; Dion, M. Granuloma pyogenicum. Ear Nose Throat J. 1977, 56, 228–233. [Google Scholar] [PubMed]
  3. Compagno, J.; Wong, R.T. Intranasal mixed tumours (pleomorphic adenomas): A clinicopathologic study of 40 cases. Am. J. Clin. Pathol. 1977, 68, 213–218. [Google Scholar] [CrossRef] [PubMed]
  4. Ho, Y.M.; Coman, W.B. Nasal septum malignancy. ANZ J. Surg. 2011, 81, 533–536. [Google Scholar] [CrossRef]
  5. Olsen, K.D. Nose and sinus tumours. In Rhinologic Diagnosis and Treatment; McCaffrey, T., Ed.; Thieme: New York, NY, USA, 1997; pp. 334–359. [Google Scholar]
  6. Sireci, F.; Dispenza, F.; Zambito, P.; Salvago, P.; Lorusso, F.; Canevari, F.R. The Minimally Invasive Sinus Surgery Technique. In Advances in Health and Disease; Duncan, L.T., Ed.; Nova Publisher: Hauppauge, NY, USA, 2021; Chapter 6; Volume 37, pp. 191–200. [Google Scholar]
  7. Sireci, F.; Lorusso, F.; Martines, F.; Salvago, P.; Immordino, A.; Dispenza, F.; Gallina, S.; Canevari, F.R. Guide to the Management of complications in Endoscopic Sinus Surgery (ESS). In Advances in Health and Disease; Duncan, L.T., Ed.; Nova Publisher: Hauppauge, NY, USA, 2021; Chapter 4; Volume 37, pp. 159–176. [Google Scholar]
  8. Sireci, F.; Speciale, R.; Sorrentino, R.; Turri-Zanoni, M.; Nicolotti, M.; Canevari, F.R. Nasal packing in sphenopalatine artery bleeding: Therapeutic or harmful? Eur. Arch. Otorhinolaryngol. 2016, 274, 1501–1505. [Google Scholar] [CrossRef]
  9. Krouse, J.H. Development of a staging system for inverted papilloma. Laryngoscope 2000, 110, 965–968. [Google Scholar] [CrossRef]
  10. Brierley, J.D.; Gospodarowicz, M.K.; Wittekind, C. (Eds.) TNM Classification of Malignant Tumours, 8th ed.; Wiley-Blackwell: Oxford, UK, 2017. [Google Scholar]
  11. Sireci, F.; Dispenza, F.; Immordino, A.; Gazia, F.; Maniaci, A.; Canevari, F.R. The Role of Clarithromycin in the Management of Chronic Rhinosinusitis. In Advances in Health and Disease; Duncan, L.T., Ed.; Nova Publisher: Hauppauge, NY, USA, 2021; Chapter 7; Volume 37, pp. 201–208. [Google Scholar]
  12. Uraih, L.C.; Maronpot, R.R. Normal histology of the nasal cavity and application of special techniques. Environ. Health Perspect. 1990, 85, 187–208. [Google Scholar] [CrossRef] [Green Version]
  13. Puxeddu, R.; Berlucchi, M.; Ledda, G.P.; Parodo, G.; Farina, D.; Nicolai, P. Lobular capillary hemangioma of the nasal cavity: A retrospective study on 40 patients. Am. J. Rhinol. 2006, 20, 480–484. [Google Scholar] [CrossRef]
  14. Lee, T.J.; Huang, C.C.; Chen, Y.W.; Chang, K.P.; Fu, C.H.; Chang, P.H. Medially originated inverted papilloma. Otolaryngol. Head Neck Surg. 2009, 140, 324–329. [Google Scholar] [CrossRef]
  15. Rha, M.S.; Jeong, S.; Cho, H.J.; Yoon, J.H.; Kim, C.H. Sinonasal pleomorphic adenoma: A single institution case series combined with a comprehensive review of literatures. Auris Nasus Larynx 2019, 46, 223–229. [Google Scholar] [CrossRef]
  16. Montana, M.; Salvago, P.; Dispenza, F. Pleomorphic adenoma of the nasal septum: A rare case report of a 14 year-old patient. EMBJ 2018, 13, 28–30. [Google Scholar]
  17. Johnson, P.E.; Karnezis, T.T.; Storper, I.S. Papillary cystadenoma of the nasal cavity. Otolaryngol. Head Neck Surg. 2007, 137, 841–842. [Google Scholar] [CrossRef] [PubMed]
  18. Lorusso, F.; Verro, B.; Dispenza, F.; Gallina, S. Respiratory epithelial adenomatoid hamartoma: An unusual case report. Otorinolaringologia 2020, 70, 86–90. [Google Scholar] [CrossRef]
  19. Bignami, M.; Volpi, L.; Karligkiotis, A.; de Bernardi, F.; Pistochini, A.; AlQahtani, A.; Meloni, F.; Verillaud, B.; Herman, P.; Castelnuovo, P. Endoscopic endonasal resection of respiratory epithelial adenomatoid hamartomas of the sinonasal tract. Int. Forum Allergy Rhinol. 2014, 4, 961–965. [Google Scholar] [CrossRef] [PubMed]
  20. Canevari, F.R.; Sireci, F.; Sollini, G. Huge septal schwannoma: Endoscopic transnasal resection using disassembling technique. Rhinologist 2017, 4, 4–11. [Google Scholar]
  21. Sireci, F.; Immordino, V.; Galletti, F.; Galletti, B.; Cimino, G.; Sbacchi, C. Cerebrospinal Fluid Leak Following Nasal Packing for Epistaxis. J. Craniofac. Surg. 2019, 30, 2536–2538. [Google Scholar] [CrossRef]
  22. Min, H.J.; Hong, S.C.; Kim, K.S. Nasal Septal Schwannoma: Advances in Diagnosis and Treatment. J. Craniofac. Surg. 2017, 28, e97–e101. [Google Scholar] [CrossRef]
  23. Thompson, L.D.R.; Lau, S.K. Sinonasal Tract Solitary Fibrous Tumor: A Clinicopathologic Study of Six Cases with a Comprehensive Review of the Literature. Head Neck Pathol. 2018, 12, 471–480. [Google Scholar] [CrossRef]
  24. Lim, L.M.; Tan, K.B.; Petersson, F.; Thong, M. Sinonasal blue naevus: Case report and clinicopathological review. J. Laryngol. Otol. 2013, 127, 939–941. [Google Scholar] [CrossRef]
  25. Dauer, E.H.; Lewis, J.E.; Rohlinger, A.L.; Weaver, A.L.; Olsen, K.D. Sinonasal melanoma: A clinicopathologic review of 61 cases. Otolaryngol.—Head Neck Surg. 2008, 138, 347–352. [Google Scholar] [CrossRef]
  26. Canevari, F.R.; Giourgos, G.; Pistochini, A. The endoscopic transnasal paraseptal approach to a sphenoid sinus osteoma: Case report and literature review. Ear Nose Throat J. 2013, 92, E7–E10. [Google Scholar] [PubMed]
  27. Giger, R.; Kurt, A.M.; Lacroix, J.S. Endoscopic removal of a nasal septum chondrosarcoma. Rhinology 2002, 40, 96–99. [Google Scholar] [PubMed]
  28. Betz, C.S.; Janda, P.; Arbogast, S.; Leunig, A. Myxoma and myxoid chondrosarcoma of the nasal septum: Two case reports. HNO 2007, 55, 51–55. [Google Scholar] [CrossRef] [PubMed]
  29. Jenny, L.; Harvinder, S.; Gurdeep, S. Endoscopic resection of primary nasoseptal chondrosarcoma. Med. J. Malays. 2008, 63, 335–336. [Google Scholar]
  30. Kleinsasser, O.; Schroeder, H.G. Adenocarcinomas of the inner nose after exposure to wood dust. Morphological findings and relationships between histopathology and clinical behavior in 79 cases. Arch. Oto-Rhino-Laryngol. 1988, 245, 1–15. [Google Scholar] [CrossRef]
  31. Barnes, L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am. J. Surg. Pathol. 1986, 10, 192–202. [Google Scholar] [CrossRef]
  32. Franchi, A.; Gallo, O.; Santucci, M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. Hum. Pathol. 1999, 30, 1140–1145. [Google Scholar] [CrossRef]
  33. Franquemont, D.W.; Fechner, R.E.; Mills, S.E. Histologic classification of sinonasal intestinal-type adenocarcinoma. Am. J. Surg. Pathol. 1991, 15, 368–375. [Google Scholar] [CrossRef]
  34. Heffner, D.K.; Hyams, V.J.; Hauck, K.W.; Lingeman, C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer 1982, 50, 312–322. [Google Scholar] [CrossRef]
  35. McKay, S.P.; Shibuya, T.Y.; Armstrong, W.B.; Wong, H.S.; Panossian, A.M.; Ager, J. Cell carcinoma of the paranasal sinuses and skull base. Am. J. Otolaryngol. 2007, 28, 294–301. [Google Scholar] [CrossRef]
  36. Von Buchwald, C.; Bradley, P.J. Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr. Opin. Otolaryngol. Head Neck Surg. 2007, 15, 95–98. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Pie chart that highlights the percentages of the different tumours of our series. LCH: Lobular capillary haemangioma; IP: Inverted Papilloma; SFT: solitary fibrous tumour; REAH: Sinonasal respiratory epithelial adenomatoid hamartoma.
Figure 1. Pie chart that highlights the percentages of the different tumours of our series. LCH: Lobular capillary haemangioma; IP: Inverted Papilloma; SFT: solitary fibrous tumour; REAH: Sinonasal respiratory epithelial adenomatoid hamartoma.
Ijerph 19 01713 g001
Figure 2. Coronal computed tomography scan showing a large solitary fibrous tumour (SFT) of the right nostril (a) and bilateral chondrosarcoma (b). The hyperostosis of nasal septum indicates the origin of SFT that compresses the medial wall of maxillary sinus, while in (b) it is showed the invasion of maxillary sinus bilaterally.
Figure 2. Coronal computed tomography scan showing a large solitary fibrous tumour (SFT) of the right nostril (a) and bilateral chondrosarcoma (b). The hyperostosis of nasal septum indicates the origin of SFT that compresses the medial wall of maxillary sinus, while in (b) it is showed the invasion of maxillary sinus bilaterally.
Ijerph 19 01713 g002
Figure 3. Flow diagram for management of tumour of nasal septum.
Figure 3. Flow diagram for management of tumour of nasal septum.
Ijerph 19 01713 g003
Table 1. Details of patients who underwent endoscopic exeresis of tumour of nasal septum.
Table 1. Details of patients who underwent endoscopic exeresis of tumour of nasal septum.
Patients
(N°)
Gender/AgeHistologySide
(Left/Right/Bilateral)
Type of Septum Resection
1F/72LCHRightMP
2M/44Inverted PapillomaRightMPwC
3M/56n-ITACLeftNS
4M/51Inverted PapillomaRightMPwC
5F/54LCHLeftMPwC
6M/65Inverted PapillomaRightMPwC
7M/73SchwannomaRightMPwC
8M/58Inverted PapillomaLeftMPwB
9F/67ChondrosarcomaBilateralNS
10F/51Inverted PapillomaRightMPwB
11F/54Warthin TumourRightMP
12M/71Inverted PapillomaRightMPwC
13F/86LCHRightMP
14M/69Inverted PapillomaRightMPwC
15F/75Inverted PapillomaRightMPwB
16F/54Blue NevusLeftNS
17M/46Inverted PapillomaLeftMPwC
18M/57SCCRightNS
19M/67Mucosal MelanomaRightNS
20M/68Inverted PapillomaLeftMPwC
21M/32Inverted PapillomaLeftMPwC
22M/41Inverted PapillomaLeftMPwC
23M/62Inverted PapillomaLeftMPwC
24M/58LCHRightMP
25M/60SFTRightMPwB
26F/55LCHRightMP
27F/57LCHLeftMP
28F/50LCHRightMP
29F/25LCHLeftMP
30M/69LCHRightMP
31F/14Pleomorphic AdenomaLeftMP
32M/46REAHRightMP
F: Female; M: Male; LCH: Lobular capillary haemangioma; n-ITAC: non-intestinal-type adenocarcinoma; SCC: Squamous Cell Carcinoma; SFT: solitary fibrous tumour; REAH: Sinonasal respiratory epithelial adenomatoid hamartoma; MP: Mucoperichondrium; MPwC/B: Mucoperichondrium with Cartilage/Bone; NS: Nasal Septum.
Table 2. Synthesis of the main characteristics present in the literature of the tumours found in our series [1].
Table 2. Synthesis of the main characteristics present in the literature of the tumours found in our series [1].
WHO Classifications of
Tumours
HistopathologyMost
Frequent Origin
in the Nose
Local
Recurrence
Malignant
Trasformation
TherapySeptal Resection
Benign Vascular TumoursLCHSeptum/NoSurgeryMP
Benign epithelial TumoursInverted papillomaLateral wall
of nasal cavity
Yes
(0–78%)
Yes
(3.6%)
SurgeryMPwC/B
Plemorphic AdenomaSeptum/Yes
(6%)
Surgery MP
Whartin’s Tumours//NoSurgeryMP
REAHPosterior
Nasal
Septum
/NoSurgeryMP
Benign soft tissue tumoursSchwannomaNaso ethmoid compartment/Yes
(10–15% in Von Recklinghausen’s disease)
SurgeryMPwC/B
Borderline and low malignant potential tumours of soft tissueSFTNasal cavity/Yes
(10–20%)
SurgeryMPwC/B
Neuro-ectodermal
Tumours
Blue nevusNasal cavityLowNoSurgeryNS
Mucosal melanomaNasal cavityHigh-Surgery
± RT
NS
Malignant tumours of bone and cartilageLow grade
chondrosarcoma
Maxillary
Sinus
/-Surgery
± RT
NS
Malignant epitelial tumoursn-ITACEthmoid sinus/-Surgery
± RT
NS
Squamous cell
carcionma
Ethmoid sinusYes (20%)-Surgery
± RT
NS
LCH: Lobular capillary haemangioma; n-ITAC: non-intestinal-type adenocarcinoma; SFT: solitary fibrous tumour; REAH: Sinonasal respiratory epithelial adenomatoid hamartoma; MP: Mucoperichondrium; MPwC/B: Mucoperichondrium with Cartilage/Bone; NS: Nasal Septum; RT: radiotherapy; “/”: missing data; “-”: feature already present.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sireci, F.; Dispenza, F.; Lorusso, F.; Immordino, A.; Immordino, P.; Gallina, S.; Peretti, G.; Canevari, F.R. Tumours of Nasal Septum: A Retrospective Study of 32 Patients. Int. J. Environ. Res. Public Health 2022, 19, 1713. https://doi.org/10.3390/ijerph19031713

AMA Style

Sireci F, Dispenza F, Lorusso F, Immordino A, Immordino P, Gallina S, Peretti G, Canevari FR. Tumours of Nasal Septum: A Retrospective Study of 32 Patients. International Journal of Environmental Research and Public Health. 2022; 19(3):1713. https://doi.org/10.3390/ijerph19031713

Chicago/Turabian Style

Sireci, Federico, Francesco Dispenza, Francesco Lorusso, Angelo Immordino, Palmira Immordino, Salvatore Gallina, Giorgio Peretti, and Frank Rikki Canevari. 2022. "Tumours of Nasal Septum: A Retrospective Study of 32 Patients" International Journal of Environmental Research and Public Health 19, no. 3: 1713. https://doi.org/10.3390/ijerph19031713

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop